12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Notable gainers included Tevogen Bio Holdings, CNS Pharma, and DBV Technologies, while Conduit Pharmaceuticals, Genprex, and Ensysce Biosciences were among the losers.
October 24, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Conduit Pharmaceuticals' stock declined by 16.9% to $0.11 in pre-market trading.
The sharp decline in Conduit Pharmaceuticals' stock price suggests negative news or sentiment, potentially leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Ensysce Biosciences' stock fell by 13.24% to $0.35 in pre-market trading.
The decline in Ensysce Biosciences' stock price suggests negative developments or sentiment, potentially leading to further short-term losses.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Genprex's stock decreased by 13.97% to $2.28 in pre-market trading.
Genprex's stock price decline indicates negative market sentiment, which could result in continued short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
CNS Pharma's stock increased by 24.04% to $0.17 in pre-market trading.
The significant rise in CNS Pharma's stock price suggests positive developments or investor interest, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
DBV Technologies' stock rose by 22.17% to $0.83 during pre-market trading.
DBV Technologies' stock price increase indicates positive investor sentiment, which could lead to continued short-term upward movement.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Tevogen Bio Holdings saw a significant pre-market stock price increase of 28.6%, reaching $3.19.
Tevogen Bio Holdings' stock price rose significantly, indicating positive market sentiment or news. This could attract short-term investors looking to capitalize on the momentum.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80